{"transactions":[{"id":700180,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Restricted Stock Units","published_at":"2026-07-31T22:00:17.000Z","date":"2026-07-29","kind":"exercise","planned":false,"acquired":false,"shares":32272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the restricted stock units vested on July 29, 2026 and 25% vest on each of July 29, 2027 and July 29, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"50% of the restricted stock units vested on July 29, 2026 and 25% vest on each of July 29, 2027 and July 29, 2028."}],"balance_after":32272,"derivative":{"underlying":"Common Stock","underlying_shares":32272},"source":{"system":"sec-edgar","filing":"0001861477-26-000005","document":"form4-07312026_060701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000186147726000005/form4-07312026_060701.xml","form_type":"4"}},{"id":700179,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Common Stock","published_at":"2026-07-31T22:00:17.000Z","date":"2026-07-30","kind":"sale","planned":false,"acquired":false,"shares":50,"price":26.17,"value":1308.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":18994,"source":{"system":"sec-edgar","filing":"0001861477-26-000005","document":"form4-07312026_060701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000186147726000005/form4-07312026_060701.xml","form_type":"4"}},{"id":700178,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Common Stock","published_at":"2026-07-31T22:00:17.000Z","date":"2026-07-30","kind":"sale","planned":false,"acquired":false,"shares":16508,"price":26.13,"value":431354.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":19044,"source":{"system":"sec-edgar","filing":"0001861477-26-000005","document":"form4-07312026_060701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000186147726000005/form4-07312026_060701.xml","form_type":"4"}},{"id":700177,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Common Stock","published_at":"2026-07-31T22:00:17.000Z","date":"2026-07-29","kind":"exercise","planned":false,"acquired":true,"shares":32272,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":35552,"source":{"system":"sec-edgar","filing":"0001861477-26-000005","document":"form4-07312026_060701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000186147726000005/form4-07312026_060701.xml","form_type":"4"}},{"id":827634,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Restricted Stock Units","published_at":"2026-03-27T00:00:12.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":false,"shares":6715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."}],"balance_after":20146,"derivative":{"underlying":"Common Stock","underlying_shares":6715},"source":{"system":"sec-edgar","filing":"0001861477-26-000003","document":"form4-03262026_080306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000186147726000003/form4-03262026_080306.xml","form_type":"4"}},{"id":827633,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:12.000Z","date":"2026-03-25","kind":"sale","planned":false,"acquired":false,"shares":3435,"price":21.47,"value":73749.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":3280,"source":{"system":"sec-edgar","filing":"0001861477-26-000003","document":"form4-03262026_080306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000186147726000003/form4-03262026_080306.xml","form_type":"4"}},{"id":827632,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:12.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":true,"shares":6715,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":6715,"source":{"system":"sec-edgar","filing":"0001861477-26-000003","document":"form4-03262026_080306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000186147726000003/form4-03262026_080306.xml","form_type":"4"}},{"id":851804,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T22:00:10.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":29548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 6, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 6, 2027."}],"balance_after":29548,"derivative":{"underlying":"Common Stock","underlying_shares":29548},"source":{"system":"sec-edgar","filing":"0001861477-26-000002","document":"form4-03102026_060307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000186147726000002/form4-03102026_060307.xml","form_type":"4"}},{"id":851803,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-10T22:00:10.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":101574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":101574,"derivative":{"exercise_price":22.16,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":101574},"source":{"system":"sec-edgar","filing":"0001861477-26-000002","document":"form4-03102026_060307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000186147726000002/form4-03102026_060307.xml","form_type":"4"}},{"id":1066638,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-14T21:25:30.000Z","date":"2025-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7196,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the \"Company\"), Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), on August 14, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a \"CVR\") subject to the terms and conditions of a Contingent Value Rights Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the \"Company\"), Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), on August 14, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a \"CVR\") subject to the terms and conditions of a Contingent Value Rights Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-021961","document":"form4-08142025_090827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000141588925021961/form4-08142025_090827.xml","form_type":"4"}},{"id":1095485,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T22:52:32.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The amount reflects partial payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":7196,"source":{"system":"sec-edgar","filing":"0001415889-25-019153","document":"form4-07022025_100728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000141588925019153/form4-07022025_100728.xml","form_type":"4"}},{"id":1183790,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T23:01:59.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The amount reflects partial payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":6502,"source":{"system":"sec-edgar","filing":"0001415889-25-009778","document":"form4-04022025_110456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000141588925009778/form4-04022025_110456.xml","form_type":"4"}},{"id":1191446,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Restricted Stock Units","published_at":"2025-03-26T23:52:56.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":26861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."}],"balance_after":26861,"derivative":{"underlying":"Common Stock","underlying_shares":26861},"source":{"system":"sec-edgar","filing":"0001415889-25-009068","document":"form4-03262025_110352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009068/form4-03262025_110352.xml","form_type":"4"}},{"id":1191445,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-26T23:52:56.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":91395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 24, 2026. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":91395,"derivative":{"exercise_price":17.23,"expiration_date":"2035-03-23","underlying":"Common Stock","underlying_shares":91395},"source":{"system":"sec-edgar","filing":"0001415889-25-009068","document":"form4-03262025_110352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009068/form4-03262025_110352.xml","form_type":"4"}},{"id":1315188,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T22:55:29.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":1452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The amount reflects partial payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":5808,"source":{"system":"sec-edgar","filing":"0001415889-25-000609","document":"form4-01032025_100126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000141588925000609/form4-01032025_100126.xml","form_type":"4"}},{"id":1394707,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T23:59:03.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":1452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The amount reflects partial payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":4356,"source":{"system":"sec-edgar","filing":"0001415889-24-024534","document":"form4-10022024_111059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000141588924024534/form4-10022024_111059.xml","form_type":"4"}},{"id":1435174,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Restricted Stock Units","published_at":"2024-08-13T22:05:04.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":64544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the restricted stock units vest on July 29, 2026 and 25% vest on each of July 29, 2027 and July 29, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"50% of the restricted stock units vest on July 29, 2026 and 25% vest on each of July 29, 2027 and July 29, 2028."}],"balance_after":64544,"derivative":{"underlying":"Common Stock","underlying_shares":64544},"source":{"system":"sec-edgar","filing":"0001415889-24-021243","document":"form4-08132024_060801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924021243/form4-08132024_060801.xml","form_type":"4"}},{"id":1435173,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of Research & Dev"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-13T22:05:04.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":324582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on July 29, 2025.  The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":324582,"derivative":{"exercise_price":15.29,"expiration_date":"2034-08-11","underlying":"Common Stock","underlying_shares":324582},"source":{"system":"sec-edgar","filing":"0001415889-24-021243","document":"form4-08132024_060801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924021243/form4-08132024_060801.xml","form_type":"4"}},{"id":1463332,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-03T00:07:23.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":1452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The amount reflects partial payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":2904,"source":{"system":"sec-edgar","filing":"0001415889-24-019057","document":"form4-07032024_120720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000141588924019057/form4-07032024_120720.xml","form_type":"4"}},{"id":1553878,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T22:25:18.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":1452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects partial payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":1452,"source":{"system":"sec-edgar","filing":"0001415889-24-009851","document":"form4-04022024_100411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000141588924009851/form4-04022024_100411.xml","form_type":"4"}},{"id":1576905,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-14T22:03:48.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":29400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the shares subject to the option shall vest each month following the Issuer's 2024 Annual Meeting of Stockholders on the same day of the month, subject to Reporting Person remaining a Service Provider through each such date. Notwithstanding the foregoing, the shares subject to the option will be fully vested no later than the date of the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":29400,"derivative":{"exercise_price":9.95,"expiration_date":"2034-03-12","underlying":"Common Stock","underlying_shares":29400},"source":{"system":"sec-edgar","filing":"0001415889-24-008035","document":"form4-03142024_100343.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000141588924008035/form4-03142024_100343.xml","form_type":"4"}},{"id":1763764,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T22:01:21.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5174,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5174},"source":{"system":"sec-edgar","filing":"0001209191-23-052363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123052363/doc4.xml","form_type":"4"}},{"id":1763763,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T22:01:21.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5174,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5174},"source":{"system":"sec-edgar","filing":"0001209191-23-052363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123052363/doc4.xml","form_type":"4"}},{"id":1763762,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T22:01:21.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10349,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10349},"source":{"system":"sec-edgar","filing":"0001209191-23-052363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123052363/doc4.xml","form_type":"4"}},{"id":1763761,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T22:01:21.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21426,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21426},"source":{"system":"sec-edgar","filing":"0001209191-23-052363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123052363/doc4.xml","form_type":"4"}},{"id":1763760,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T22:01:21.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12854,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12854},"source":{"system":"sec-edgar","filing":"0001209191-23-052363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123052363/doc4.xml","form_type":"4"}},{"id":1763759,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T22:01:21.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4285,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 8 to this Form 4\") vest 2/3rd on January 5, 2024 and the remaining shares vest on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 8 to this Form 4\") vest 2/3rd on January 5, 2024 and the remaining shares vest on January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4285},"source":{"system":"sec-edgar","filing":"0001209191-23-052363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123052363/doc4.xml","form_type":"4"}},{"id":1763758,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T22:01:21.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20697,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the disposition of Issuer's restricted stock unit awards, excluding PSUs (as defined in footnote 8 to this Form 4), (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was assumed and converted into a restricted stock unit (each, a \"Parent RSU\") denominated in shares of Parent's common stock. The number of shares of Parent's common stock subject to each such Parent RSU was equal to the product (rounded down to the nearest whole number) of (y) the number of shares of Ordinary Shares subject to the RSU immediately prior to the Effective Time multiplied by (z) the ratio equal to (1) the Consideration divided by (2) the volume weighted average of the per share closing price of Parent's common stock on the Nasdaq for five (5) trading days ending on the second business day prior to the completion of the Scheme."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20697},"source":{"system":"sec-edgar","filing":"0001209191-23-052363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123052363/doc4.xml","form_type":"4"}},{"id":1763757,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T22:01:21.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14283,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the disposition of Issuer's restricted stock unit awards, excluding PSUs (as defined in footnote 8 to this Form 4), (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was assumed and converted into a restricted stock unit (each, a \"Parent RSU\") denominated in shares of Parent's common stock. The number of shares of Parent's common stock subject to each such Parent RSU was equal to the product (rounded down to the nearest whole number) of (y) the number of shares of Ordinary Shares subject to the RSU immediately prior to the Effective Time multiplied by (z) the ratio equal to (1) the Consideration divided by (2) the volume weighted average of the per share closing price of Parent's common stock on the Nasdaq for five (5) trading days ending on the second business day prior to the completion of the Scheme."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Ordinary Shares subject to the RSUs vest ratably on January 5, 2024 and January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Ordinary Shares subject to the RSUs vest ratably on January 5, 2024 and January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14283},"source":{"system":"sec-edgar","filing":"0001209191-23-052363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123052363/doc4.xml","form_type":"4"}},{"id":1763756,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T22:01:21.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4657,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU (as defined in footnote 4 to this Form 4) and PSU (as defined in footnote 8 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the disposition of Issuer's restricted stock unit awards, excluding PSUs (as defined in footnote 8 to this Form 4), (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was assumed and converted into a restricted stock unit (each, a \"Parent RSU\") denominated in shares of Parent's common stock. The number of shares of Parent's common stock subject to each such Parent RSU was equal to the product (rounded down to the nearest whole number) of (y) the number of shares of Ordinary Shares subject to the RSU immediately prior to the Effective Time multiplied by (z) the ratio equal to (1) the Consideration divided by (2) the volume weighted average of the per share closing price of Parent's common stock on the Nasdaq for five (5) trading days ending on the second business day prior to the completion of the Scheme."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Ordinary Shares subject to the RSUs (as defined in footnote 4 to this Form 4\") vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Ordinary Shares subject to the RSUs (as defined in footnote 4 to this Form 4\") vest on January 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4657},"source":{"system":"sec-edgar","filing":"0001209191-23-052363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123052363/doc4.xml","form_type":"4"}},{"id":1763755,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2023-10-06T22:01:21.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14575,"price":116.5,"value":1697987.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of ordinary shares of Horizon Therapeutics plc (\"Issuer\"), nominal value $0.0001 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement (the \"Transaction Agreement\"), dated as of December 11, 2022, by and among Issuer, Amgen Inc. (\"Parent\"), and Pillartree Limited, a wholly owned subsidiary of Parent (\"Acquirer Sub\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Acquirer Sub acquired Issuer. Pursuant to the Transaction Agreement, on October 6, 2023, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $116.50 in cash (the \"Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-052363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123052363/doc4.xml","form_type":"4"}},{"id":1764396,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-05T23:43:42.000Z","date":"2023-10-03","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on October 3, 2024 and 1/36 of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":31000,"derivative":{"exercise_price":6.71,"expiration_date":"2033-10-03","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001209191-23-052262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123052262/doc4.xml","form_type":"4"}},{"id":1954456,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2023-03-14T20:45:22.000Z","date":"2023-03-13","kind":"gift","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14575,"source":{"system":"sec-edgar","filing":"0001209191-23-018502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123018502/doc4.xml","form_type":"4"}},{"id":2060661,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units (RSU)","published_at":"2023-01-06T22:43:23.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":20697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest 1/3rd annually on each anniversary of January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest 1/3rd annually on each anniversary of January 5, 2023."}],"balance_after":20697,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20697},"source":{"system":"sec-edgar","filing":"0001209191-23-002435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123002435/doc4.xml","form_type":"4"}},{"id":2068483,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units (RSU)","published_at":"2023-01-04T21:18:21.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":7141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025."}],"balance_after":14283,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7141},"source":{"system":"sec-edgar","filing":"0001209191-23-000896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123000896/doc4.xml","form_type":"4"}},{"id":2068482,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units (RSU)","published_at":"2023-01-04T21:18:21.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":4657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The remaining ordinary shares subject to the RSU vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The remaining ordinary shares subject to the RSU vest on January 5, 2024."}],"balance_after":4657,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4657},"source":{"system":"sec-edgar","filing":"0001209191-23-000896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123000896/doc4.xml","form_type":"4"}},{"id":2068481,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units (RSU)","published_at":"2023-01-04T21:18:21.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":7257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The final tranche of ordinary shares subject to the RSU vested on December 30, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The final tranche of ordinary shares subject to the RSU vested on December 30, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7257},"source":{"system":"sec-edgar","filing":"0001209191-23-000896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123000896/doc4.xml","form_type":"4"}},{"id":2068480,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2023-01-04T21:18:21.000Z","date":"2022-12-30","kind":"tax_withholding","acquired":false,"shares":9449,"price":113.8,"value":1075296.2,"ownership":{"direct":true},"balance_after":16575,"source":{"system":"sec-edgar","filing":"0001209191-23-000896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123000896/doc4.xml","form_type":"4"}},{"id":2068479,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2023-01-04T21:18:21.000Z","date":"2022-12-30","kind":"exercise","acquired":true,"shares":19055,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":26024,"source":{"system":"sec-edgar","filing":"0001209191-23-000896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919123000896/doc4.xml","form_type":"4"}},{"id":2204613,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2022-07-20T22:19:33.000Z","date":"2022-07-20","kind":"sale","acquired":false,"shares":5917,"price":85,"value":502945.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022."}],"balance_after":6969,"source":{"system":"sec-edgar","filing":"0001209191-22-042767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919122042767/doc4.xml","form_type":"4"}},{"id":2204612,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2022-07-20T22:19:33.000Z","date":"2022-07-19","kind":"sale","acquired":false,"shares":82,"price":85.04,"value":6973.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022."}],"balance_after":12886,"source":{"system":"sec-edgar","filing":"0001209191-22-042767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919122042767/doc4.xml","form_type":"4"}},{"id":2204611,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2022-07-20T22:19:33.000Z","date":"2022-07-19","kind":"sale","acquired":false,"shares":8,"price":85.015,"value":680.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022."}],"balance_after":12968,"source":{"system":"sec-edgar","filing":"0001209191-22-042767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919122042767/doc4.xml","form_type":"4"}},{"id":2209265,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2022-07-11T22:03:04.000Z","date":"2022-07-07","kind":"sale","acquired":false,"shares":82,"price":85.01,"value":6970.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022."}],"balance_after":12976,"source":{"system":"sec-edgar","filing":"0001209191-22-041840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919122041840/doc4.xml","form_type":"4"}},{"id":2294060,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2022-04-20T20:13:30.000Z","date":"2022-04-18","kind":"sale","acquired":false,"shares":8098,"price":115.64,"value":936452.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.96 to $116.185 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13058,"source":{"system":"sec-edgar","filing":"0001209191-22-024924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919122024924/doc4.xml","form_type":"4"}},{"id":2441815,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-07T02:01:01.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":4657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2021."}],"balance_after":9314,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4657},"source":{"system":"sec-edgar","filing":"0001209191-22-002295","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919122002295/doc4.xml","form_type":"4"}},{"id":2441814,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-07T02:01:01.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":7257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":7257,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7257},"source":{"system":"sec-edgar","filing":"0001209191-22-002295","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919122002295/doc4.xml","form_type":"4"}},{"id":2441813,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-07T02:01:01.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":2085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2085},"source":{"system":"sec-edgar","filing":"0001209191-22-002295","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919122002295/doc4.xml","form_type":"4"}},{"id":2441812,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-07T02:01:01.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":21424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2022."}],"balance_after":21424,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21424},"source":{"system":"sec-edgar","filing":"0001209191-22-002295","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919122002295/doc4.xml","form_type":"4"}},{"id":2441811,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2022-01-07T02:01:01.000Z","date":"2022-01-05","kind":"tax_withholding","acquired":false,"shares":7030,"price":101.84,"value":715935.2,"ownership":{"direct":true},"balance_after":21156,"source":{"system":"sec-edgar","filing":"0001209191-22-002295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919122002295/doc4.xml","form_type":"4"}},{"id":2441810,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2022-01-07T02:01:01.000Z","date":"2022-01-05","kind":"exercise","acquired":true,"shares":13999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":28186,"source":{"system":"sec-edgar","filing":"0001209191-22-002295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919122002295/doc4.xml","form_type":"4"}},{"id":2611784,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2021-08-06T21:03:41.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":7542,"price":106.3411,"value":802024.5762,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.31 to $106.515 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14187,"source":{"system":"sec-edgar","filing":"0001209191-21-050212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919121050212/doc4.xml","form_type":"4"}},{"id":2645311,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units","published_at":"2021-07-02T21:02:14.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":12077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":0,"derivative":{"exercise_date":"2021-07-01","expiration_date":"2021-07-01","underlying":"Ordinary Shares","underlying_shares":12077},"source":{"system":"sec-edgar","filing":"0001209191-21-045062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919121045062/doc4.xml","form_type":"4"}},{"id":2645310,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2021-07-02T21:02:14.000Z","date":"2021-07-01","kind":"tax_withholding","acquired":false,"shares":5988,"price":96.59,"value":578380.92,"ownership":{"direct":true},"balance_after":21729,"source":{"system":"sec-edgar","filing":"0001209191-21-045062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919121045062/doc4.xml","form_type":"4"}},{"id":2645309,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":27578,"kind":"person","name":"Thompson Elizabeth H.Z.","position":1,"cik":"0001861477","reported_name":"Thompson Elizabeth H.Z.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Ordinary Shares","published_at":"2021-07-02T21:02:14.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":12077,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":27717,"source":{"system":"sec-edgar","filing":"0001209191-21-045062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861477/000120919121045062/doc4.xml","form_type":"4"}}]}